TickerFactsScreenerDevelopers

Atara Biotherapeutics, Inc. (ATRA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $3.0K2014: $46.0K2015: $290.0K2016: $3.02M2017: $20.23M2018: $35.92M2019: $5.73M2020: $4.51M2021: $10.58M2022: $4.19M2023: $1.22M2024: $246.0K2025: $0$0
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$246.0K-79.9%
2023$1.22M-70.8%
2022$4.19M-60.4%
2021$10.58M+134.4%
2020$4.51M-21.3%
2019$5.73M-84.0%
2018$35.92M+77.6%
2017$20.23M+569.9%
2016$3.02M+941.4%
2015$290.0K+530.4%
2014$46.0K+1433.3%
2013$3.0K—